PT2709638E - Composição de mel com l-alanil-lglutamina - Google Patents
Composição de mel com l-alanil-lglutamina Download PDFInfo
- Publication number
- PT2709638E PT2709638E PT127235208T PT12723520T PT2709638E PT 2709638 E PT2709638 E PT 2709638E PT 127235208 T PT127235208 T PT 127235208T PT 12723520 T PT12723520 T PT 12723520T PT 2709638 E PT2709638 E PT 2709638E
- Authority
- PT
- Portugal
- Prior art keywords
- composition
- honey
- glutamine
- sleep
- analyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 52
- 235000012907 honey Nutrition 0.000 title claims description 51
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 title description 22
- 229960002648 alanylglutamine Drugs 0.000 title description 22
- 230000007958 sleep Effects 0.000 claims description 38
- 239000000047 product Substances 0.000 claims description 21
- 239000008196 pharmacological composition Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 206010022437 insomnia Diseases 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 201000002859 sleep apnea Diseases 0.000 claims description 3
- 239000013066 combination product Substances 0.000 claims 8
- 229940127555 combination product Drugs 0.000 claims 8
- 210000004556 brain Anatomy 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 229920002527 Glycogen Polymers 0.000 description 8
- 229940096919 glycogen Drugs 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 6
- 230000003860 sleep quality Effects 0.000 description 6
- 230000006266 hibernation Effects 0.000 description 5
- 230000004617 sleep duration Effects 0.000 description 5
- 241000257303 Hymenoptera Species 0.000 description 4
- 208000019116 sleep disease Diseases 0.000 description 4
- 230000004620 sleep latency Effects 0.000 description 4
- 108010016626 Dipeptides Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 102000004375 Insulin-like growth factor-binding protein 1 Human genes 0.000 description 3
- 108090000957 Insulin-like growth factor-binding protein 1 Proteins 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000002618 waking effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000478 neocortex Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Insects & Arthropods (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicinal Preparation (AREA)
- Seasonings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1108343.3A GB201108343D0 (en) | 2011-05-18 | 2011-05-18 | Honey composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2709638E true PT2709638E (pt) | 2016-01-07 |
Family
ID=44260736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT127235208T PT2709638E (pt) | 2011-05-18 | 2012-05-16 | Composição de mel com l-alanil-lglutamina |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10314879B2 (enExample) |
| EP (1) | EP2709638B1 (enExample) |
| JP (2) | JP6328552B2 (enExample) |
| KR (1) | KR101900904B1 (enExample) |
| CN (2) | CN103747791B (enExample) |
| AU (1) | AU2012257566B2 (enExample) |
| CA (1) | CA2834182C (enExample) |
| CY (1) | CY1117053T1 (enExample) |
| DK (1) | DK2709638T3 (enExample) |
| ES (1) | ES2553655T3 (enExample) |
| GB (1) | GB201108343D0 (enExample) |
| HR (1) | HRP20151320T1 (enExample) |
| HU (1) | HUE028293T2 (enExample) |
| MX (1) | MX337139B (enExample) |
| PL (1) | PL2709638T3 (enExample) |
| PT (1) | PT2709638E (enExample) |
| RS (1) | RS54412B1 (enExample) |
| SI (1) | SI2709638T1 (enExample) |
| SM (1) | SMT201600056B (enExample) |
| WO (1) | WO2012156731A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201108343D0 (en) * | 2011-05-18 | 2011-06-29 | Hibernation Honey Ltd | Honey composition |
| US20190175685A1 (en) * | 2016-08-01 | 2019-06-13 | Filament Biosolutions Inc. | Methods of treating and preventing cancer treatment side effects |
| HUE057583T2 (hu) * | 2016-12-30 | 2022-05-28 | Innobio Corporation Ltd | Alanil-glutamin dipeptid bioszintetikus enzimet kódoló gén és alkalmazása |
| CN113040393A (zh) * | 2021-03-31 | 2021-06-29 | 杨继辉 | 一种干预焦虑睡眠障碍的营养配方 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2919059A1 (de) | 1979-05-10 | 1980-11-20 | Josef Dipl Chem Dr Rer N Klosa | Diaetetisches mittel und verfahren zu seiner herstellung |
| US4532143A (en) * | 1984-06-15 | 1985-07-30 | The J. M. Smucker Company | Spreadable honey |
| US4973491A (en) * | 1989-06-06 | 1990-11-27 | Ontario Ministry Of Agriculture And Food | Honey product |
| JP2829793B2 (ja) | 1991-01-10 | 1998-12-02 | 長谷川香料株式会社 | 飲食品の蜂蜜様風味改善方法 |
| GB9121467D0 (en) | 1991-10-10 | 1991-11-27 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| JP3473976B2 (ja) * | 1992-10-29 | 2003-12-08 | 協和醗酵工業株式会社 | アラニルグルタミンの製造法 |
| NZ538405A (en) | 2002-08-01 | 2007-12-21 | Aesgen Inc | Improved treatment of cancer with glutamine and carbohydrate |
| JP4595651B2 (ja) * | 2005-04-25 | 2010-12-08 | 株式会社デンソー | 生体センサ、睡眠情報処理方法、及び睡眠情報処理装置 |
| US20100197787A1 (en) * | 2005-10-12 | 2010-08-05 | Masako Doi | Composition for Prevention of Hypoglycemic Condition |
| CN101312660B (zh) * | 2005-11-23 | 2013-07-17 | 可口可乐公司 | 供体重管理之高效甜味剂以及经彼甜化的组成物 |
| US20100234308A1 (en) | 2006-03-23 | 2010-09-16 | Kyowa Hakko Kogyo Co., Ltd. | Wake-up remedy |
| WO2007108530A1 (ja) * | 2006-03-23 | 2007-09-27 | Kyowa Hakko Kogyo Co., Ltd. | 筋肉疲労改善剤 |
| JP5046364B2 (ja) * | 2006-09-15 | 2012-10-10 | パナソニック株式会社 | 睡眠状況評価システム及びそのプログラム |
| CN101041008A (zh) | 2007-04-28 | 2007-09-26 | 王军 | 三冬丹 |
| EP2177113A1 (en) | 2008-10-15 | 2010-04-21 | Nestec S.A. | Improved liver glycocen synthesis |
| JP2010260853A (ja) * | 2009-04-08 | 2010-11-18 | Kyowa Hakko Bio Co Ltd | アラニルグルタミンを含有する造粒粉末、顆粒または錠剤 |
| CN101999572A (zh) * | 2010-11-08 | 2011-04-06 | 王福起 | 助眠蜜及制备方法 |
| GB201108343D0 (en) * | 2011-05-18 | 2011-06-29 | Hibernation Honey Ltd | Honey composition |
-
2011
- 2011-05-18 GB GBGB1108343.3A patent/GB201108343D0/en not_active Ceased
-
2012
- 2012-05-16 CN CN201280023801.9A patent/CN103747791B/zh not_active Expired - Fee Related
- 2012-05-16 HR HRP20151320TT patent/HRP20151320T1/hr unknown
- 2012-05-16 DK DK12723520.8T patent/DK2709638T3/da active
- 2012-05-16 KR KR1020137032788A patent/KR101900904B1/ko not_active Expired - Fee Related
- 2012-05-16 PL PL12723520T patent/PL2709638T3/pl unknown
- 2012-05-16 JP JP2014510877A patent/JP6328552B2/ja not_active Expired - Fee Related
- 2012-05-16 AU AU2012257566A patent/AU2012257566B2/en not_active Ceased
- 2012-05-16 CA CA2834182A patent/CA2834182C/en active Active
- 2012-05-16 MX MX2013012967A patent/MX337139B/es active IP Right Grant
- 2012-05-16 HU HUE12723520A patent/HUE028293T2/en unknown
- 2012-05-16 EP EP12723520.8A patent/EP2709638B1/en active Active
- 2012-05-16 PT PT127235208T patent/PT2709638E/pt unknown
- 2012-05-16 ES ES12723520.8T patent/ES2553655T3/es active Active
- 2012-05-16 RS RS20150811A patent/RS54412B1/sr unknown
- 2012-05-16 SI SI201230398T patent/SI2709638T1/sl unknown
- 2012-05-16 WO PCT/GB2012/051090 patent/WO2012156731A1/en not_active Ceased
- 2012-05-16 CN CN201810011129.0A patent/CN108159391A/zh active Pending
- 2012-05-16 US US14/114,649 patent/US10314879B2/en active Active
-
2015
- 2015-12-17 CY CY20151101156T patent/CY1117053T1/el unknown
-
2016
- 2016-02-24 SM SM201600056T patent/SMT201600056B/xx unknown
- 2016-10-27 JP JP2016210960A patent/JP6336003B2/ja not_active Expired - Fee Related
-
2019
- 2019-02-25 US US16/283,918 patent/US20190192612A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2834182C (en) | 2021-05-18 |
| SMT201600056B (it) | 2016-04-29 |
| DK2709638T3 (da) | 2015-12-21 |
| KR20140058435A (ko) | 2014-05-14 |
| AU2012257566A1 (en) | 2013-11-14 |
| CN108159391A (zh) | 2018-06-15 |
| EP2709638A1 (en) | 2014-03-26 |
| CN103747791B (zh) | 2018-01-30 |
| GB201108343D0 (en) | 2011-06-29 |
| MX337139B (es) | 2016-02-12 |
| HUE028293T2 (en) | 2016-12-28 |
| SI2709638T1 (sl) | 2016-01-29 |
| MX2013012967A (es) | 2014-05-13 |
| JP6336003B2 (ja) | 2018-06-06 |
| JP6328552B2 (ja) | 2018-05-23 |
| KR101900904B1 (ko) | 2018-09-21 |
| HK1196097A1 (en) | 2014-12-05 |
| EP2709638B1 (en) | 2015-09-30 |
| US20190192612A1 (en) | 2019-06-27 |
| AU2012257566B2 (en) | 2017-03-02 |
| US20140186457A1 (en) | 2014-07-03 |
| JP2014513713A (ja) | 2014-06-05 |
| US10314879B2 (en) | 2019-06-11 |
| JP2017061488A (ja) | 2017-03-30 |
| WO2012156731A1 (en) | 2012-11-22 |
| CN103747791A (zh) | 2014-04-23 |
| RS54412B1 (sr) | 2016-04-28 |
| CY1117053T1 (el) | 2017-04-05 |
| PL2709638T3 (pl) | 2016-03-31 |
| CA2834182A1 (en) | 2012-11-22 |
| HRP20151320T1 (hr) | 2016-01-15 |
| ES2553655T3 (es) | 2015-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2306465T3 (es) | Procedimiento para la reduccion a largo plazo de almacenes de grasa corporal,resistencia a insulina,hiperinsulinemia e hiperglucemia en vertebrados. | |
| CN104366510B (zh) | 茶叶茶氨酸保健食品组合物及其制备方法 | |
| AU2008319747B2 (en) | Anti-fatigue agent comprising amino acid composition | |
| JP2001508801A (ja) | リーンボディーマスを増進させ、感情の障害および体重異常の治療に用いるフォルスコーリン | |
| US20190192612A1 (en) | Honey composition with l-alanyl-l-glutamine | |
| CN108159382B (zh) | 一种治疗伴有焦虑抑郁的失眠症的药物 | |
| US20080058405A1 (en) | Replicating melatonin signaling in a fetus, newborn or suckling infant | |
| JP2000026289A (ja) | 分岐鎖アミノ酸による筋肉痛・筋肉のこり、はりへの効果 | |
| CN102125576A (zh) | 甘草苷在制备防治心脑血管疾病药物中的应用 | |
| CN108354080A (zh) | 一种肥胖期专用减肥犬粮的制备方法 | |
| HK1196097B (en) | Honey composition with l-alanyl- l- glutamine | |
| Freund et al. | Nitrogen sparing effects and mechanisms of branched-chain amino acids in the injured rat | |
| ES2319048B1 (es) | Uso de leptina en el tratamiento de alteraciones en los habitos alimentarios. | |
| Nusynowitz | The isolation of thyroxine | |
| CN121129961A (zh) | 一种协同改善睡眠和日间疲劳的中药组合物及制备方法和应用 | |
| BEARD | LACK OF RESPONSE TO ANTERIOR PITUITARY GROWTH PRINCIPLE | |
| Miloszewski et al. | Increase in urinary indican excretion in pancreatic steatorrhoea following replacement therapy | |
| Sundin | Nutrition for the Critically Ill | |
| BR102017003855A2 (pt) | composição de liberação modificada para readequar relógio biológico humano e uso de uma composição de liberação modificada para readequar relógio biológico humano | |
| Swenson | TESTOSTERONE aka The Fountain of Youth | |
| CN102716139A (zh) | 甘草苷在制备防治脑缺血疾病药物中的应用 | |
| CN102716141A (zh) | 甘草苷在制备防治脑缺氧疾病药物中的应用 | |
| CN102716140A (zh) | 甘草苷在制备防治脑血栓疾病药物中的应用 | |
| CN101336956A (zh) | 霜豆利胆丸 |